Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Citurgia BiochemicalsBOM:506373 13 EBIT per Share is ₹-0.06 as of Mar. 2026. GuruFocus rates BOM:506373 with a GF Score™ of 13/100. The stock has 2 warning signs investors should review. Among 1,336 Chemicals companies, Citurgia Biochemicals ranks better than 85.33% on this metric.
Citurgia Biochemicals's EBIT per Share for the
three
months ended in Mar. 2026 was ₹-0.02.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was ₹-0.06.
During the past 3 years, the average EBIT per Share Growth Rate was 30.20% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 28.40% per year.
During the past 10 years, the average EBIT per Share Growth Rate was -3.20% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Citurgia Biochemicals's EBIT per Share or its related term are showing as below:
BOM:506373'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -76.8 Med: 10.2 Max: 45.5
Current: 30.2
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Citurgia Biochemicals was 45.50% per year. The lowest was -76.80% per year. And the median was 10.20% per year.
BOM:506373's 3-Year EBIT Growth Rate is ranked better than 85.33% of 1336
companies
in the Chemicals industry
Industry Median: -1.05
vs BOM:506373: 30.20
Citurgia Biochemicals (BOM:506373) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Citurgia Biochemicals EBIT per Share Related Terms
Citurgia Biochemicals EBIT per Share Historical Data
* Premium members only.
The historical data trend for Citurgia Biochemicals's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-0.06
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Citurgia Biochemicals (BOM:506373) has a EBIT per Share of ₹-0.06 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Citurgia Biochemicals and its competitors. According to the industry distribution chart, Citurgia Biochemicals ranks #196 out of 1336 companies in the Chemicals industry, placing it in the top 14.7%.
Is Citurgia Biochemicals' EBIT per Share too high?
Citurgia Biochemicals' current EBIT per Share is ₹-0.06. Based on the distribution chart, Citurgia Biochemicals ranks #196 out of 1336 companies in the Chemicals industry, which is in the top quartile — a strong position relative to peers. Overall, Citurgia Biochemicals has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Citurgia Biochemicals' EBIT per Share compare to DOW?
According to the Chemicals industry distribution chart, Citurgia Biochemicals ranks #196 out of 1336 companies for EBIT per Share. This places Citurgia Biochemicals in the top 15% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Chemicals company?
A good EBIT per Share depends on the Chemicals industry context. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Citurgia Biochemicals and its competitors. Citurgia Biochemicals's current EBIT per Share is ₹-0.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Citurgia Biochemicals stock overvalued right now?
Citurgia Biochemicals (BOM:506373) has a current EBIT per Share of ₹-0.06. The current EBIT per Share is ₹-0.06. Citurgia Biochemicals' overall GF Score™ is 13/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Citurgia Biochemicals (BOM:506373), the current EBIT per Share is ₹-0.06 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Citurgia Biochemicals Ltd is an India-based company engaged in manufacturing citric acid, calcium carbonate, and plasticizers. Citric acid is traditionally used in foods, soft drinks, confectionery, and drugs. It is also used in chemicals, where it provides stable pH conditions for polyester and nylon. Acrylic print-curing and cotton-resist printing.
13GF Score
Get the complete analysis for BOM:506373
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:506373 has been successfully added to your 
